Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Other financing activities (2010 - 2016)

Microbot Medical posted quarterly Other financing activities of $29834.0 for Q3 2016, up 389.16% year-on-year from $6099.0 in Q4 2015, and down 14.33% on a QoQ basis from $34824.0 in Q2 2016.

Microbot Medical (MBOT) has 7 years of Other financing activities data on file, last reported at $29834.0 in Q3 2016.

  • For the quarter ending Q3 2016, Other financing activities rose 389.16% year-over-year to $29834.0; the trailing twelve-month figure through Sep 2016 stood at $289969.0 (down 26.14% YoY), and the FY2018 full-year result was $18000.0, changed N/A from the prior year.
  • Other financing activities for Q3 2016 stood at $29834.0, down from $34824.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $297871.0 in Q2 2014 and bottomed at $6099.0 in Q3 2015.
  • The 5-year median for Other financing activities is $58293.0 (2013), against an average of $113096.1.
  • The widest annual swing landed in 2012, when Other financing activities plunged 93.16%; it then jumped 1736.5% in 2013.
  • A 5-year view of Other financing activities shows it stood at $29225.0 in 2012, then plunged by 58.89% to $12015.0 in 2013, then soared by 2379.16% to $297871.0 in 2014, then plunged by 97.95% to $6099.0 in 2015, then jumped by 389.16% to $29834.0 in 2016.
  • The last three Other financing activities figures came in at $29834.0 (Q3 2016), $34824.0 (Q2 2016), and $225311.0 (Q1 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Microbot Medical 118.87 Mn 49.22 Mn 2,000.00

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 29,834.00
Sep 30, 2016 29,834.00
Jun 30, 2016 34,824.00
Jun 30, 2016 34,824.00
Mar 31, 2016 225,311.00
Mar 31, 2016 225,311.00
Sep 30, 2015 6,099.00
Sep 30, 2015 6,099.00
Jun 30, 2015 243,805.00
Jun 30, 2015 243,805.00
Mar 31, 2015 142,683.00
Mar 31, 2015 142,683.00
Jun 30, 2014 297,871.00
Jun 30, 2014 297,871.00
Mar 31, 2014 201,462.00
Mar 31, 2014 201,462.00
Sep 30, 2013 12,015.00
Sep 30, 2013 12,015.00
Jun 30, 2013 81,762.00
Jun 30, 2013 81,762.00
Mar 31, 2013 248,589.00
Mar 31, 2013 248,589.00
Sep 30, 2012 29,225.00
Sep 30, 2012 29,225.00
Jun 30, 2012 16,329.00
Jun 30, 2012 16,329.00
Mar 31, 2012 13,536.00
Mar 31, 2012 13,536.00
Dec 31, 2011 7,424.00
Dec 31, 2011 7,424.00
Sep 30, 2011 2,105.00
Sep 30, 2011 2,105.00
Jun 30, 2011 196,339.00
Jun 30, 2011 196,339.00
Mar 31, 2011 197,757.00
Mar 31, 2011 197,757.00
Sep 30, 2010 6,847.00
Sep 30, 2010 6,847.00